Summary for 8EQE
Entry DOI | 10.2210/pdb8eqe/pdb |
Related | 8EQ9 8EQD |
Descriptor | Eukaryotic translation initiation factor 2-alpha kinase 3, (2R)-N-[(4M)-4-(4-amino-2,7-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-3-methylphenyl]-2-hydroxy-2-[3-(trifluoromethyl)phenyl]acetamide (3 entities in total) |
Functional Keywords | kinase, perk, inhibitor, transferase |
Biological source | Homo sapiens (human) More |
Total number of polymer chains | 1 |
Total formula weight | 37285.82 |
Authors | Zhu, G.,Surman, M.D.,Mulvihill, M.J. (deposition date: 2022-10-07, release date: 2022-11-30, Last modification date: 2023-10-25) |
Primary citation | Stokes, M.E.,Surman, M.D.,Calvo, V.,Surguladze, D.,Li, A.H.,Gasparek, J.,Betzenhauser, M.,Zhu, G.,Du, H.,Rigby, A.C.,Mulvihill, M.J. Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors. Pharmaceutics, 14:-, 2022 Cited by PubMed: 36297668DOI: 10.3390/pharmaceutics14102233 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.559 Å) |
Structure validation
Download full validation report